Examining the Use of Glucose and Physical Activity Self-Monitoring Technologies in Individuals at Moderate to High Risk of Developing Type 2 Diabetes: Randomized Trial.
Maxine E WhelanMark W OrmeAndrew P KingsnorthLauren B SherarFrancesca L DentonDale W EsligerPublished in: JMIR mHealth and uHealth (2019)
International Standard Randomized Controlled Trial Number (ISRCTN) 17545949; isrctn.com/ISRCTN17545949.